UK Radiodermatitis Market Size & Outlook, 2023-2030
UK radiodermatitis market, 2018-2030 (US$M)
Related Markets
UK radiodermatitis market highlights
- The UK radiodermatitis market generated a revenue of USD 11.6 million in 2023 and is expected to reach USD 14.6 million by 2030.
- The UK market is expected to grow at a CAGR of 3.4% from 2024 to 2030.
- In terms of segment, topical was the largest revenue generating product in 2023.
- Topical is the most lucrative product segment registering the fastest growth during the forecast period.
Radiodermatitis market data book summary
| Market revenue in 2023 | USD 11.6 million |
| Market revenue in 2030 | USD 14.6 million |
| Growth rate | 3.4% (CAGR from 2023 to 2030) |
| Largest segment | Topical |
| Fastest growing segment | Topical |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Topical, Dressings |
| Key market players worldwide | Smith & Nephew PLC, Integra LifeSciences, ConvaTec Group PLC, 3M Co, Molnlycke Health Care, Alliqua BioMedical, Stratpharma, BMG Pharma |
Other key industry trends
- In terms of revenue, UK accounted for 2.9% of the global radiodermatitis market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany radiodermatitis market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 12.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Radiodermatitis Market Scope
Radiodermatitis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UK radiodermatitis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiodermatitis market will help companies and investors design strategic landscapes.
Topical was the largest segment with a revenue share of 74.14% in 2023. Horizon Databook has segmented the UK radiodermatitis market based on topical, dressings covering the revenue growth of each sub-segment from 2018 to 2030.
The UK is the largest market of Europe for the radiodermatitis and expected to grow at steady rates owing to well-established healthcare system. The increasing incidence of radiation radiation burns in radiation cancer therapy is expected to fuel the market growth in this region.
Moreover, the number of non-profit organizations such as British Radiation burn Association, which aim towards providing, and propagating the knowledge on best treatment and rehabilitation following a radiation burn injury are increasing thereby boosting the market growth in this region.
Reasons to subscribe to UK radiodermatitis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UK radiodermatitis market databook
-
Our clientele includes a mix of radiodermatitis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UK radiodermatitis market , including forecasts for subscribers. This country databook contains high-level insights into UK radiodermatitis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UK radiodermatitis market size, by product, 2018-2030 (US$M)
UK Radiodermatitis Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
